398 related articles for article (PubMed ID: 9263704)
1. Insulin resistance in polycystic ovary syndrome.
Prelevic GM
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):193-201. PubMed ID: 9263704
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and the long-term consequences of polycystic ovary syndrome.
Bhathena RK
J Obstet Gynaecol; 2011; 31(2):105-10. PubMed ID: 21281021
[TBL] [Abstract][Full Text] [Related]
3. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
4. Hyperinsulinemia in polycystic ovary disease.
Arthur LS; Selvakumar R; Seshadri MS; Seshadri L
J Reprod Med; 1999 Sep; 44(9):783-7. PubMed ID: 10509302
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.
Nácul AP; Andrade CD; Schwarz P; de Bittencourt PI; Spritzer PM
Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):191-6. PubMed ID: 17049715
[TBL] [Abstract][Full Text] [Related]
7. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
8. Associated non-ovarian problems of polycystic ovarian disease: insulin resistance.
Chang RJ; Geffner ME
Clin Obstet Gynaecol; 1985 Sep; 12(3):675-85. PubMed ID: 3905162
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
Nardo LG; Patchava S; Laing I
Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
[TBL] [Abstract][Full Text] [Related]
10. Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome.
Spritzer PM; Comim FV; Capp E; D'Avila A
Horm Metab Res; 2005 Feb; 37(2):94-8. PubMed ID: 15778926
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome and type 2 diabetes mellitus.
De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
[TBL] [Abstract][Full Text] [Related]
12. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome.
Poretsky L; Piper B
Obstet Gynecol; 1994 Oct; 84(4):613-21. PubMed ID: 8090402
[TBL] [Abstract][Full Text] [Related]
14. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
[TBL] [Abstract][Full Text] [Related]
15. Hyperinsulinemia does not influence androgens/estrogens ratio in patients with polycystic ovarian syndrome.
Panidis DK; Rousso DH; Matalliotakis IM; Kourtis AI; Vlassis GD; Koumantakis EE
Int J Fertil Womens Med; 1999; 44(6):301-6. PubMed ID: 10617252
[TBL] [Abstract][Full Text] [Related]
16. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
Diamanti-Kandarakis E; Papavassiliou AG
Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and adolescent girls with polycystic ovary syndrome.
Bhattacharya SM; Ghosh M
J Pediatr Adolesc Gynecol; 2010 Jun; 23(3):158-61. PubMed ID: 19963413
[TBL] [Abstract][Full Text] [Related]
19. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
Corbould A
Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]